Recently, Peifer et al. [11] reported recurrent genomic rearrangements affecting the expression of telomerase reverse transcriptase gene (TERT), which significantly separates high-risk neuroblastoma from low-risk. The gene discussed is TERT; the disease is neuroblastoma.